Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 Focused Updates: ACC/AHA Guidelines for STEMI and ACC/AHA/SCAI Guidelines for PCI
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:1093-1100, doi:10.1016/j.jacc.2005.11.046 (Published online 21 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.11.046v1
47/6/1093    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (112)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grundy, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grundy, S. M.

STATE-OF-THE-ART PAPER

Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds

Scott M. Grundy, MD, PhD*,*

Center for Human Nutrition and Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Manuscript received October 6, 2005; revised manuscript received October 28, 2005, accepted November 1, 2005.

* Reprint requests and correspondence: Dr. Scott M. Grundy, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Y3.206, Dallas, Texas 75390-9052. (Email: scott.grundy{at}utsouthwestern.edu).

The metabolic syndrome is a constellation of risk factors of metabolic origin that are accompanied by increased risk for cardiovascular disease and type 2 diabetes. These risk factors are atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a prothrombotic state, and a proinflammatory state. The two major underlying risk factors for the metabolic syndrome are obesity and insulin resistance; exacerbating factors are physical inactivity, advancing age, and endocrine and genetic factors. The condition is progressive, beginning with borderline risk factors that eventually progress to categorical risk factors. In many patients, the metabolic syndrome culminates in type 2 diabetes, which further increases risk for cardiovascular disease. Primary treatment of the metabolic syndrome is lifestyle therapy—weight loss, increased physical activity, and anti-atherogenic diet. But as the condition progresses, drug therapies directed toward the individual risk factors might be required. Ultimately, it might be possible to develop drugs that will simultaneously modify all of the risk factors. At present such drugs are in development but so far have not reached the level of clinical practice.

Abbreviations and Acronyms
  ASCVD = atherosclerotic cardiovascular disease
  ATP III = Adult Treatment Panel III
  CB1 = cannabinoid receptor-1
  HDL = high-density lipoprotein
  IDF = International Diabetes Federation
  LDL = low-density lipoprotein
  NCEP = National Cholesterol Education Program
  PPAR = peroxisome proliferator-activated receptor
  TZD = thiazolidinedione
  WHO = World Health Organization




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Yokota, S. Kinugawa, K. Hirabayashi, S. Matsushima, N. Inoue, Y. Ohta, S. Hamaguchi, M. A. Sobirin, T. Ono, T. Suga, et al.
Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice
Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1069 - H1077.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
H. A. Amundson, M. K. Butcher, D. Gohdes, T. O. Hall, T. S. Harwell, S. D. Helgerson, K. K. Vanderwood, and for the Montana Cardiovascular Disease and Diabete
Translating the Diabetes Prevention Program Into Practice in the General Community: Findings From the Montana Cardiovascular Disease and Diabetes Prevention Program
The Diabetes Educator, March 1, 2009; 35(2): 209 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Giani, M. A. Mayer, M. C. Munoz, E. A. Silberman, C. Hocht, C. A. Taira, M. M. Gironacci, D. Turyn, and F. P. Dominici
Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats
Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E262 - E271.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. M. Thorn, C. Forsblom, J. Waden, J. Soderlund, M. Rosengard-Barlund, M. Saraheimo, O. Heikkila, K. Hietala, K. Pettersson-Fernholm, J. Ilonen, et al.
Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes
Diabetes Care, January 1, 2009; 32(1): 63 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. A. West, R. F. Hamman, E. J. Mayer-Davis, R. B. D'Agostino Jr., S. M. Marcovina, A. D. Liese, P. S. Zeitler, S. R. Daniels, and D. Dabelea
Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
Diabetes Care, January 1, 2009; 32(1): 175 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel
The Metabolic Syndrome
Endocr. Rev., December 1, 2008; 29(7): 777 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
L. M Title, E. Lonn, F. Charbonneau, M. Fung, K. J Mather, S. Verma, and T. J Anderson
Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome
Vascular Medicine, November 1, 2008; 13(4): 263 - 270.
[Abstract] [PDF]

Home page
 Psychosom. Med.Home page
K. L. Chichlowska, K. M. Rose, A. V. Diez-Roux, S. H. Golden, A. M. McNeill, and G. Heiss
Individual and Neighborhood Socioeconomic Status Characteristics and Prevalence of Metabolic Syndrome: The Atherosclerosis Risk in Communities (ARIC) Study
Psychosom Med, November 1, 2008; 70(9): 986 - 992.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Cabou, G. Campistron, N. Marsollier, C. Leloup, C. Cruciani-Guglielmacci, L. Penicaud, D. J. Drucker, C. Magnan, and R. Burcelin
Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
Diabetes, October 1, 2008; 57(10): 2577 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, and A. P. DeFilippis
A Practical 'ABCDE' Approach to the Metabolic Syndrome
Mayo Clin. Proc., August 1, 2008; 83(8): 932 - 943.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A. Negron, M. Molina, A. Mayor, V. Rodriguez, and L. Vila
Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico
Lupus, April 1, 2008; 17(4): 348 - 354.
[Abstract] [PDF]

Home page
 DiabetesHome page
M. Falchi, S. G. Wilson, D. Paximadas, R. Swaminathan, and T. D. Spector
Quantitative Linkage Analysis for Pancreatic B-cell Function and Insulin Resistance in a Large Twin Cohort
Diabetes, April 1, 2008; 57(4): 1120 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
K G M M Alberti and P Z Zimmet
Should we dump the metabolic syndrome? No
BMJ, March 22, 2008; 336(7645): 641 - 641.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
R. W. Nesto and K. Mackie
Endocannabinoid system and its implications for obesity and cardiometabolic risk
Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B34 - B41.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
I. Protopsaltis, P. Korantzopoulos, H. J. Milionis, A. Koutsovasilis, G. K. Nikolopoulos, E. Dimou, S. Kokkoris, P. Brestas, M. S. Elisaf, and A. Melidonis
Metabolic Syndrome and Its Components as Predictors of Ischemic Stroke in Type 2 Diabetic Patients
Stroke, March 1, 2008; 39(3): 1036 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Nagel, K. Rapp, M. Wabitsch, G. Buchele, A. Kroke, I. Zollner, S. K. Weiland, and W. Koenig
Prevalence and Cluster of Cardiometabolic Biomarkers in Overweight and Obese Schoolchildren: Results from a Large Survey in Southwest Germany
Clin. Chem., February 1, 2008; 54(2): 317 - 325.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. M. Sironi, A. Pingitore, S. Ghione, D. De Marchi, B. Scattini, V. Positano, E. Muscelli, D. Ciociaro, M. Lombardi, E. Ferrannini, et al.
Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat
Hypertension, February 1, 2008; 51(2): 282 - 288.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
O. A. Iakoubova, C. H. Tong, C. M. Rowland, T. G. Kirchgessner, B. A. Young, A. R. Arellano, D. Shiffman, M. S. Sabatine, H. Campos, C. J. Packard, et al.
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 435 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. White, T. Guerin, H. Swanson, S. Post, H. Zhu, M. Gong, J. Liu, W. V. Everson, X.-A. Li, G. A. Graf, et al.
Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C295 - C305.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
S. D De Ferranti and S. K Osganian
Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus
Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 285 - 296.
[Abstract] [PDF]

Home page
 DiabetesHome page
C. Cabou, P. D. Cani, G. Campistron, C. Knauf, C. Mathieu, C. Sartori, J. Amar, U. Scherrer, and R. Burcelin
Central Insulin Regulates Heart Rate and Arterial Blood Flow: An Endothelial Nitric Oxide Synthase Dependent Mechanism Altered During Diabetes
Diabetes, December 1, 2007; 56(12): 2872 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. C. Kem, X. Yu, E. Patterson, S. Huang, S. Stavrakis, B. Szabo, L. Olansky, J. McCauley, and M. W. Cunningham
Autoimmune Hypertensive Syndrome
Hypertension, November 1, 2007; 50(5): 829 - 834.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. Ruggiero, A. Cherubini, S. S. Najjar, and L. Ferrucci
Reply
J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1810 - 1811.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Korantzopoulos, M. Elisaf, and H. J. Milionis
Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time?
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2768 - 2774.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Barazzoni, M. Zanetti, C. Ferreira, P. Vinci, A. Pirulli, M. Mucci, F. Dore, M. Fonda, B. Ciocchi, L. Cattin, et al.
Relationships between Desacylated and Acylated Ghrelin and Insulin Sensitivity in the Metabolic Syndrome
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3935 - 3940.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. M Hill, J. D Buckley, K. J Murphy, and P. R. Howe
Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1267 - 1274.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Q. Shaibi, M. L. Cruz, M. J. Weigensberg, C. M. Toledo-Corral, C. J. Lane, L. A. Kelly, J. N. Davis, C. Koebnick, E. E. Ventura, C. K. Roberts, et al.
Adiponectin Independently Predicts Metabolic Syndrome in Overweight Latino Youth
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1809 - 1813.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. Kahn
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Circulation, April 3, 2007; 115(13): 1806 - 1811.
[Full Text] [PDF]

Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
T. B. Repas
Challenges and Strategies in Managing Cardiometabolic Risk
J Am Osteopath Assoc, April 1, 2007; 107(4_suppl_2): S4 - S11.
[Abstract] [Full Text] [PDF]

Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
J. S. Freeman
Reducing the "Domino Effect" of the Metabolic Syndrome
J Am Osteopath Assoc, April 1, 2007; 107(4_suppl_2): Cov2 - S3.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada
Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?
Circ. Res., March 30, 2007; 100(6): 795 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
L. W. Johnson and R. S. Weinstock
The Metabolic Syndrome: Concepts and Controversy
Mayo Clin. Proc., December 1, 2006; 81(12): 1615 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. H. Lewis, M. Legato, and H. Fisch
Medical Implications of the Male Biological Clock.
JAMA, November 15, 2006; 296(19): 2369 - 2371.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Devaraj, E. Chan, and I. Jialal
Direct Demonstration of an Antiinflammatory Effect of Simvastatin in Subjects with the Metabolic Syndrome
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4489 - 4496.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Bajaj and O. Ben-Yehuda
A Big Fat Wedding: Association of Adiponectin With Coronary Vascular Lesions
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1163 - 1165.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. Blaha and T. A. Elasy
Clinical Use of the Metabolic Syndrome: Why the Confusion?
Clin. Diabetes, July 1, 2006; 24(3): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn
The Metabolic Syndrome (Emperor) Wears No Clothes
Diabetes Care, July 1, 2006; 29(7): 1693 - 1696.
[Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement